Journal of Patient-Centered
Research and Reviews
Volume 7

Issue 1

Article 4

1-27-2020

Anxiety-Related Issues in Cancer Survivorship
Maresi A. Berry-Stoelzle
Anna C. Mark
Peter Kim
Jeanette M. Daly

Follow this and additional works at: https://aah.org/jpcrr
Part of the Neoplasms Commons, Oncology Commons, Other Psychiatry and Psychology Commons,
Primary Care Commons, and the Psychiatric and Mental Health Commons

Recommended Citation
Berry-Stoelzle MA, Mark AC, Kim P, Daly JM. Anxiety-related issues in cancer survivorship. J Patient Cent
Res Rev. 2020;7:31-8. doi: 10.17294/2330-0698.1711

Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal
focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes,
and the patient experience.

ORIGINAL RESEARCH

Anxiety-Related Issues in Cancer Survivorship
Maresi A. Berry-Stoelzle, MD, PhD, Anna C. Mark, MD, Peter Kim, MD, MPH, Jeanette M. Daly, PhD, RN
Department of Family Medicine, University of Iowa Carver College of Medicine, Iowa City, IA

Purpose	
The purpose of this qualitative study was to examine patient opinions about anxiety in cancer
survivorship, particularly the role of the primary care provider in management of anxiety related to the
trajectory of long-term cancer survivorship.
Methods	Respondents to a mass email (N=22,000) were invited to participate in 1 of 3 institutional review
board-approved focus group meetings. Inclusion criteria were being an adult patient older than 25
years of age, having any type of cancer diagnosis, and being at least 18 months from treatment. The
following specific issues were discussed: role of the primary care provider during and after therapy;
the transition to primary care after therapy was finished; and advice the survivors would give to
providers and cancer survivors. Focus group meetings were audio-recorded and later transcribed and
reviewed by members of the research team using constant comparison methods.
Results 	Three 2-hour focus groups were conducted to interview 22 cancer survivors. We found 5 main themes
related to anxiety in cancer survivorship: memory of anxiety; anxiety related to possible cancer
recurrence; role of close relationship with the health care provider in anxiety management; frequency
of communication in reduction of anxiety symptoms; and effect of anxiety on future health decisions
posttreatment.
Conclusions	Survivors described anxiety persisting throughout cancer diagnosis and treatment and well into
survivorship. They reported receiving care from primary care providers as well as oncologists.
Anxiety was discussed by most participants as a significant part of their experience with cancer.
(J Patient Cent Res Rev. 2020;7:31-38.)
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T

he projected number of patients with a history
of cancer in the United States is expected
to increase from 13.7 million in 2012 to 18
million by 2022, with a 37% increase for those
who will live 5 or more years after diagnosis.1
The fragmentation of posttherapy care often leads
to uncertainty on who is responsible for managing
anxiety as well as other psychosocial needs.
Anxiety disorders, as defined by the Diagnostic
and Statistical Manual of Mental Disorders, Fifth

Correspondence: Maresi A. Berry-Stoelzle, MD, PhD,
University of Iowa Carver College of Medicine,
01291-C Pomerantz Family Pavilion, 200 Hawkins Drive,
Iowa City, IA 52242 (maresi-berry@uiowa.edu)

Original Research

Edition, share features of excessive fear and anxiety.
While fear is the response to an imminent threat,
anxiety is anticipation of future threat manifesting
as excessive and persistent fear or worry.2 Attention
to anxiety is an important psychosocial aspect of
cancer survivorship care.3,4
The prevalence of anxiety is higher in survivors
of cancer compared to healthy controls, and this
difference persists in patients whose cancer was
diagnosed 10 or more years previously.5 Anxiety can
negatively impact quality of life in cancer survivors,6
impacting mental health and functioning and
increasing the severity of somatic symptoms.7 In 2008,
the Institute of Medicine reported that addressing
psychosocial needs of patients is part of quality
cancer care.8 Current American Society of Clinical
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Oncology (ASCO) guidelines state that all health
providers should routinely screen patients with cancer
and survivors for anxiety.9 Less than half of survivors
report having a discussion about psychosocial needs
with a health care provider.10 Discussing psychosocial
needs helps identify otherwise undetected needs and
provides an opportunity for treatment or referral for
those needs.10
Previous work has found that more than half of
survivors report fear of recurrence even years
after cancer diagnosis.11 Increased anxiety in these
participants influenced their decisions, which may
affect their quality of life.12 Survivors’ reported quality
of life at 1, 3, and 5 years after diagnosis showed a
perceived decrease in all domains, particularly with
regard to anxiety and depression.6,13,14 Arrieta et al
reported an association between depression and poor
treatment adherence in patients with lung cancer.15
Literature from other life-altering diseases noted
a deleterious effect of anxiety on quality of life in
patients on dialysis and those who received kidney
transplants.15-17 In patients with cancer, Mutsaers
et al differentiated when fear of cancer recurrence
becomes clinical.18 It is here where cancer survivors
benefit from therapy.19
As the number of survivors increases and past patients
become more removed in time and geography from
their initial cancer treatment, primary care providers
(PCP) are well placed to address and manage anxiety
within this patient population.20 Studies of cancer
survivorship trajectories identify different pathways
for cancer-related worry and posttraumatic growth.19
This includes adapting care, including the diagnosis
and management of anxiety that often occurs.21 PCPs
are experienced in adapting therapy to patient needs.
The purpose of this study was to examine patient
opinions about where and which health care provider
group should diagnose and address anxiety-related
issues in cancer survivorship. Our theoretical
framework leans on the work of Martin et al and
Ratcliff et al, in which cancer survivorship is
described as a trajectory.12,19 Of importance, the
provider must not only assess whether anxiety or
depression is present but determine whether it is
clinically significant and warrants intervention.18 We
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are particularly interested in the current and potential
roles of PCPs in survivorship care along this patientcentered trajectory.

METHODS

After institutional review board approval was
obtained in April 2017, a mass email message
(N=22,000) was distributed to the University of Iowa
campus community once. Convenience sampling was
used for the focus groups.22 Participants were then
selected on a first-come first-served basis. Participants
included patients who met the following eligibility
criteria: 1) adult patient greater than 25 years old;
2) history of cancer diagnosis; and 3) at least 18
months from completion of definitive cancer therapy,
including radiation, surgery, or chemotherapy. After
participation in the focus group, a $20 gift card was
provided to participants to partially compensate them
for their time.
Two-hour focus groups of posttreatment cancer
survivors were conducted in a conference room at
the University of Iowa Health Care’s Department
of Family Medicine (Iowa City, IA). This provided
a neutral space for the focus groups.23 At each focus
group, participants were initially asked to briefly
introduce themselves and describe their unique
experience with cancer. The moderator (M.B-S.,
female) then used targeted questions and prompts
to ensure specific issues guided the focus group
interviews.23 These issues included the role of the
PCP during and after cancer therapy, the transition
to primary care after therapy was finished, and
advice the study participants would give to PCPs
and survivors of cancer. With the consent of the
participants, focus groups were audio-recorded and 2
designated notetakers were present at each meeting.23
The recordings were later transcribed and reviewed
by members of the research team (1 family physician,
2 medical students, and 1 research scientist).
Transcripts were read and coded separately by 4
different members of the research team. The raw
coding techniques used by the researchers varied
from line-by-line gerund coding to thematic coding.24
Table 1 shows the code book used and applied to the
transcripts. After the initial coding was completed,
discussions about emerging themes took place. All

Original Research

Table 1. Code Book Used to Identify Themes Related to Anxiety in Cancer Survivorship
A

Unmet needs

A1
A2
A3
A4

Social
Physical
Mental
Other

B

Everyday routines

B1
B2
B3

Interaction with family
Interaction with work
Other interactions

C

Treatment end

C1
C2
C3
C4

What comes after
Who drives the transition
Integrating follow-up care into end of treatment
Formal structured clinic – survivorship

D

Emotional needs

D1

Self

D2
D3

Others
Stigma about

E

Physical needs

E1
E2

Managing long-term side effects
Other complications

F

Self-identity

F1
F2

Change due to cancer dx/thx
Same – what has not changed since the dx/thx

G
H
I

Developing a new community
Emotional ties to treating team
Social support

G1
H1
I1
I2
I3
I4

Family
Other nonmedical
Cancer center
Other medical

J

Communication

J1
J2
J3
J4
J5

Patient feelings about
Importance of
Different connections
Patient with physicians
Among physicians/providers

K

Emotional care

K1
K2
K3

Before
During
After

L

Primary care

L1
L2

What to PCP
When to PCP

M

Sources of information (who or
where patients turn for info about
how to manage their cancer)

M1

Medical therapy

M2

Nonmedical therapy

N

Physician’s role

N1
N2
N3
N4

Oncologist
PCP (any primary care specialty acting as PCP
– may include OB/GYN, etc)
Other specialist
Unclear
Matter of fact
Positive
Negative
Mixed

O

Emotion to cancer survivorship

O1
O2
O3
O4

P

Awareness of timeline (how and
when patients become aware of
timelines, either by dx, work-up,
thx, or time since certain events)
Medical condition

P1

Q

Q1
Q2
Q3

D1.1
D1.2
D1.3

Oncologist
PCP
Other provider

Cancer
Other diseases
Holistic care

dx, diagnosis; OB/GYN, obstetrics and gynecology; PCP, primary care provider; thx, therapy.
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data relevant to anxiety were then extracted. The
constant comparison method was used, for a total of
2 cycles, with each coder to make comparisons within
and between transcripts in order to identify common
themes with respect to anxiety.24

RESULTS

We conducted 3 focus groups totaling 20 women and
2 men, with ages ranging from the 30s to the 70s.
Time since treatment ranged from 18 months to many
years. Cancer types among the participants included
breast, prostate, testicular, non-Hodgkin’s lymphoma,
osteosarcoma, ovarian, thyroid, uterine, fallopian
tube, melanoma, and vaginal. Of the 22 participants,
7 had either the same type of recurring cancer or were
survivors of multiple cancer types.
The survivors in our focus groups described anxiety
persisting through cancer diagnosis, treatment, and
well into survivorship. Participants discussed anxiety
surrounding many facets of their lives. We found
5 main themes related to anxiety: the memory of
anxiety, anxiety related to possible cancer recurrence,
the role of the provider in management of anxiety, the
importance of communication, and the influence of
anxiety on future health decisions.
Memory of Anxiety
Participants discussed experiencing anxiety during
the survivorship phase as a result of the anxiety
experienced during cancer diagnosis and treatment.
Participants even compared the anxiety felt during
the survivorship phase as similar to posttraumatic
stress disorder (PTSD), a condition that causes
patients to be distressed by the mental recollection
of past traumatic events. While the participants did
not specifically disclose whether they had a medical
diagnosis of anxiety disorder or PTSD, the term PTSD
was mentioned by more than one participant. They
described the memory of anxiety associated with the
cancer diagnosis and treatment as strong enough to
evoke intense anxiety years after cancer treatment
was completed.
“… My experience of going to oncology versus

going to my internal med [physician] is it’s almost
like I had a little bit of a PTSD response to go back
into the oncology clinic.”
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Participants defined anxiety as one of the long-term
mental health effects of cancer and cancer treatment.
They discussed how the anxiety they felt during cancer
diagnosis and treatment was oftentimes overlooked
and not addressed. This anxiety then stayed with
participants and continued into the survivorship
phase. The memory of the anxiety they experienced
drove many of these participants to request a greater
emphasis be placed on the mental health aspect of care
for cancer patients and survivors.
“… My recommendation to somebody who is just
coming out of the treatment would be, really sort of
keep an eye on your own mental health. I think that’s
really important, because those around don’t always
perceive what’s going on or don’t understand why
you’re going through this, because I don’t think a
lot of people understand, just like you were saying.
They don’t have any understanding of the depth of
what cancer is exactly.”
Anxiety Related to Possible Cancer Recurrence
One of the most common causes of anxiety discussed
by participants was anxiety related to possible
cancer recurrence. Anxiety associated with possible
recurrence was present in survivors regardless of
recency of treatment.
“It’s [Cancer’s] something, you know, you’re always
worried about something coming back.”
The possibility of a cancer recurrence was described as
a constant source of anxiety lasting years after cancer
treatment was completed. Anxiety associated with
cancer recurrence caused distress in the daily lives of
survivors and changed the way survivors view their
health and body.
“… You do not trust your body after you’ve had
cancer. And it takes a long time to, I mean, I’m not
sure I ever [got] trust back — after 20 years, I did
start trusting and then I got the ovarian [cancer].”
Role of Health Care Provider (Primary Care or
Oncologist) in Anxiety Management
Participants had differing opinions as to which
provider was best equipped to manage anxiety. Some
participants expressed having a close relationship with
their oncologists. There was more trust in the oncologist
compared to other providers due to knowledge of the
cancer and treatment course. These participants felt
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more comfortable going directly to their oncologists
with health concerns, including anxiety, and had
difficulty trusting other providers
“Anytime there was kind of, if I had a worrisome
symptom, I would have gone back to see my
oncologist.”
Other participants described a close relationship
with their PCP. These participants felt their PCP had
deeper insight into aspects of care, such as mental
health and anxiety, when compared to the oncologist.
Participants described struggling with anxiety and
other mental health issues that went unnoticed by
oncology providers. In these situations, the PCP was
able to assess and treat the concerns. Participants
expressed feeling more comfortable in talking about
mental health with the PCP.
“I was on antidepressants and anti-anxiety meds,
so my primary care doctor was really helpful with
this. It was pretty stressful and depressing, and
anxiety-producing. So he kept, um, he kept me
going and adjusted the medications for me.”
Communication Reduced Anxiety Symptoms
Anxiety was often coupled with communication
during the focus group discussions. Participants
described increased communication helped to
decrease anxiety. They shared having access to a
provider helped to relieve anxiety, while no access
became a source of anxiety. The main forms of access
discussed were phone calls and emails. Lack of access
left participants feeling isolated and alone, which led
to increased anxiety.
“I just want somebody that will return my calls,
cause I get concerned about my health, I get really
anxious.”
Participants also discussed anxiety related to
communication between patient and provider.
Participants who had close relationships with their
PCP outlined close communication throughout
cancer treatment. They expressed that this helped
relieve anxiety.
“She [PCP] called me regularly and would — when
I had to have tests, before my surgery, and treatment,
and tests all along the way — she was the one who
always called me first with the results. When I was
panicking, she would call me and say, ‘Come see me
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right now; we are gonna talk.’ I don’t know what I
would have done without her.”
Participants explained that knowing communication
existed between oncology and primary care helped
to relieve anxiety. They described feeling more
comfortable in returning to the PCP and having
increased trust in the care provided because they
were aware communication took place between
oncology and primary care. Without clear evidence
of communications between oncologists and other
providers, participants felt increased anxiety when
transitioning out of oncology care.
“… Because I know all of my records are in one
place, everything is in there, and I know for a fact
that she [PCP] talks to my medical oncologist, who
is still following me, and my surgical oncologist, and
my radiation oncologist. … I feel very comfortable
[with the PCP] because I know the communication
is, is so good.”
Transitioning out of oncology care can be very
stressful. Participants were often not clear on who
to contact during the first months after the end of
oncology care, or even when that end should be.
Most participants denied having a survivorship care
plan or having a discussion about survivorship care
with a provider. Some participants described the
positive experience of having a PCP who helped to
facilitate that transition and who became the person
for the survivor to contact with concerns. Participants
emphasized the importance of communication and
how knowing who to contact could help relieve
anxiety.
“I think, you know, everybody is so overwhelmed.
When they [the oncologists] release a patient,
ideally this person [from the cancer center] should
talk to this person [PCP]. [Oncologists should
communicate with the PCP,] ‘Here, I’m sending
them back. These are the things [that are important
regarding this patient’s cancer management]. Let’s
talk.’”
 When they [oncology] turned me loose, I was glad
“
that I had a primary care [sic], because I felt like I
was jumping off a cliff. … And I had that primary
care doctor, which was helpful. It made me feel like
I had a soft landing under me.”
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Influence of Anxiety on Future Health Decisions
Participants described the influence anxiety had on
decisions they made regarding their health. This
included deciding whether to have procedures or further
testing, whether to try new medications or supplements,
and which location to have tests performed and/or
receive care. These participants described how the
influence lasted years after treatment completion.
“I didn’t have reconstruction until 10 years out,
because I was concerned about recurrence,
and how would I know? Would I miss it if I had
reconstruction? And I, so I went through this whole,
am I still female? You know, I don’t have breasts, but
can I stand up and, you know, be proud of my scars,
and I’m a warrior, and I survived, or do I hunch?
And it was, it was a battle for 10 years.”

DISCUSSION

For the survivors of cancer in our focus groups,
anxiety was a common condition through all the
phases of their cancer care — diagnosis, treatment,
and survivorship. The memory of the anxiety felt
while going through the process of cancer diagnosis
and treatment was still felt years after treatment
completion. Some participants described PTSD-like
feelings in looking back on their experience. Intrusive
symptoms associated with the traumatic event start
long after the event occurs. These include distressing
memories, recurrent dreams, flashbacks, or other
similar symptoms. Firmin et al addressed triggering
events as generating events.2,14 A positive correlation
has been reported between survivors of cancer and
PTSD.25 Our research demonstrates the memory
of anxiety in survivors of cancer continues to have
an impact after treatment is completed. This is in
line with previous research showing the prevalence
of anxiety is greater in survivors of cancer versus
healthy controls.5
Some participants preferred oncologists to provide
anxiety-related care, whereas others preferred the
PCP. Often, oncologists and PCPs also will have
differing opinions on who should be providing what
type of care for survivors of cancer.26 Ongoing care
includes general health maintenance, which would
cover mental health and anxiety.27 However, a 2004
survey of ASCO members showed that only 61.2% of
its members reported feeling comfortable providing
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general medical care to survivors.28 On the other
hand, both patients and general practitioners support
a greater role for the general practitioner in followup cancer care.21 Regardless of which provider
addressed anxiety, participants found relief if anxiety
was addressed. Current ASCO guidelines state that all
providers should screen for anxiety from the time of
cancer diagnosis and onward.9 Our research showed
this is not always the case for cancer survivors;
however, addressing anxiety is exceedingly important
as the relative risk of anxiety is statistically significant
10 or more years after the cancer diagnosis.5 A study
into long-term follow-up duration with oncology
in pediatric cancer patients showed less than 50%
of pediatric patients received follow-up care from
oncology 10 years after treatment.29 Family physicians
are an important component of follow-up care,
particularly for cancers with extended posttherapy
survival, such as breast, prostate, and those with a
history of childhood cancer.30-34
Consistent with previous research, our study showed
that anxiety is an ongoing challenge for survivors
of cancer along the survivorship timeline.19,35 Our
findings also identified where patients successfully
find care for their anxiety and explored how patients
want their anxiety addressed. The subthemes identified
under anxiety included the memory of anxiety, possible
cancer recurrence, the role of the provider in anxiety
management, extent of communication, and the
influence of anxiety on future health decisions. Anxiety
was discussed by most participants, particularly the
need to address and manage this concern. The focus
group data support a role for primary care in assessing
and managing anxiety for survivors of cancer. The data
also underscore the need for improved communication
between all stakeholders, including oncologists, PCPs,
and patients, to enhance the quality of care received by
survivors of cancer.
Focus groups showed participants felt increased
anxiety when communication was decreased. One
way to combat this anxiety is discussing survivorship
care. According to Blanch-Hartigan et al, 64% of
oncologists reported discussing survivorship care
recommendations with survivors while only 32%
of oncologists reported discussing who the survivor
should see for cancer-related or other follow-up care.36
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These low percentages are reflected in the anxiety
expressed by participants in the focus groups. Anxiety
has been described as an unmet need, since less
than half of the survivors report a discussion with a
provider about psychosocial needs.10 This underscores
the importance of addressing anxiety in survivors
of cancer,13,19 as some participants described intense
anxiety, and further emphasizes the need for anxiety
screening and treatment in this growing patient
population.1
Limitations
While symptoms and issues related to anxiety were
reported by focus group participants, we do not know
how many patients were diagnosed with anxiety
disorder. Anxiety related to specific types of cancer
diagnosis and stage were not explored. Our results do
not provide information on which of the 5 main themes
should be prioritized in the clinical setting.
Future areas of study for this topic include a more
in-depth investigation into anxiety screening and
treatment modalities available to cancer survivors in
the primary care setting. Additional work might entail
the development of evidence-based interventions
for different survivorship trajectories based on
expression of the anxiety/depression themes and
the clinical severity. This would most likely involve
a multimodal approach consisting of traditional
pharmacologic, behavioral, and cognitive therapies
as well as new methods such as the internet-based
cognitive behavioral therapy studied by Karageorge
and colleagues.37

CONCLUSIONS

The survivors of cancer who participated in our focus
group described anxiety as a significant condition
and part of their cancer experience that persisted
throughout diagnosis, treatment, and well into
survivorship. Cancer survivorship trajectories are not
one-size-fits-all, and the associated “best therapy” will
be multifactorial. Primary care providers should be
well trained to manage anxiety in cancer survivorship.
Patients continue to go to their PCP for medical
care after cancer diagnosis and therapy, thus PCPs
may be best poised to improve the quality of cancer
survivorship care as it pertains to alleviating anxiety.
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Patient-Friendly Recap
• Millions of cancer survivors live longer than 5
years after their cancer treatment ends, yet
how anxiety is best managed during extended
survivorship is unknown.
• Through focus group interviews, the authors
identified 5 main issues related to anxiety:
1) memory of anxiety lingers for years; 2)
possibility of cancer recurrence induces
anxiety; 3) relationship with health care
provider impacts anxiety management; 4)
frequency of communication can reduce
anxiety symptoms; and 5) anxiety affects
future health decisions.
• The authors suggest that, while different
patient survivorship trajectories require different
approaches to care, primary care providers
should be well positioned to manage appropriate
anxiety therapy for cancer survivors.
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